Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years. - Estepp JH; Kalpatthi R; Woods G; Trompeter S; Liem RI; Sims K; Inati A; Inusa BPD; Campbell A; Piccone C; Abboud MR; Smith-Whitley K; et al. (Pediatric blood & cancer, 2022)